Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zeta Corporation is a biotechnology company based in Arcadia, California, specializing in the design and manufacture of high-quality antibodies for immunohistochemistry (IHC). The company focuses on providing diagnostic tools for pathology, specifically targeting cancer biomarkers to aid in accurate tumor classification and diagnosis. Their extensive product portfolio includes IVD-certified monoclonal antibodies that are engineered for superior sensitivity and specificity in formalin-fixed paraffin-embedded (FFPE) tissues. Zeta utilizes advanced hybridoma technology to develop unique clones, often referred to as "Zeta-designed" antibodies, which are widely used in clinical laboratories globally. By focusing on the needs of surgical pathologists, the company provides essential reagents for identifying various malignancies, including carcinomas, melanomas, and lymphomas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zeta Corporation.